...
首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?
【24h】

Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?

机译:使用双能X射线吸收测定患者非功能性肾上腺辐射瘤和中间表型的患者的体组合物评价:是与代谢综合征有关吗?

获取原文
获取原文并翻译 | 示例

摘要

PurposeMetabolic syndrome (MS) and sarcopenia are associated with increased cardiovascular risk. No studies using dual-energy x-ray absorptiometry (DXA) have evaluated association between body composition (BC) changes and MS in adrenal incidentaloma (AI). Our aim was to analyse BC in non-functioning AI (NFAI) and intermediate phenotype (IP) relative to controls and to correlate with cortisol levels.MethodsCross-sectional study with 44 NFAI (serum cortisol50nmol/L after the overnight 1mg dexamethasone suppression test), 27 IP (cortisol 51-138nmol/L), and 41 controls (normal adrenal on imaging examination) using DXA. Autonomic cortisol secretion (cortisol>138nmol/L) was excluded from the study. BC data were compared using criteria for MS (World Health Organization, National Cholesterol Education Program-Adult Treatment Panel-III, American Association of Clinical Endocrinologists (AACE), and International Diabetes Federation).ResultsThere was no significant difference in clinical data and body mass index (BMI) among the three groups. Waist circumference (WC) was larger in AI vs. controls (p<0.01). Waist-to-hip ratio was higher in NFAI vs. controls and waist-to-height ratio was higher in IP vs. controls (p=0.03 and p=0.02, respectively). The frequency of MS was higher in AI vs. controls. BC was not different among the groups. Patients with AI there was a significant association of MS with both an increase in total fat and body fat index (all criteria), and a significant difference between MS and smaller BMI-adjusted lean mass (AACE, p=0.036). No correlation of cortisol after 1mg dexamethasone test with BC or MS. AI and WC were independently associated with MS.ConclusionsAI presented high frequency of MS and was independently associated with MS. Possible deleterious effects of cortisol secretion seem to initially affect the muscular system.
机译:purposemetabolic综合征(MS)和Sarcopenia与心血管风险增加有关。无需使用双能X射线吸收测定法(DXA)的研究已经评估了身体成分(BC)变化与肾上腺辐射瘤(AI)中的MS之间的关联。我们的目标是分析相对于对照的非功能性AI(NFAI)和中间表型(IP)中的BC,并与皮质醇水平相关。用44个NFAI(血清皮质醇50Nmol / L过夜1Mg地塞米松抑制试验后)剖视图研究) ,27个IP(皮质醇51-138nmol / L)和41个控制(成像检查正常肾上腺)使用DXA。自主式皮质醇分泌(皮质醇> 138nmol / L)被排除在研究之外。使用MS的标准进行比较BC数据(世界卫生组织,国家胆固醇教育计划 - 成人治疗小组-III,美国临床内分泌学家(AACE协会)和国际糖尿病联合会)。临床数据和体重没有显着差异三组中的索引(BMI)。腰围(WC)在AI对照中较大(P <0.01)。 NFAI与髋关节比率较高,IP对照和高度比率较高,IP对照较高(分别为P = 0.03和P = 0.02)。 AI对控制的MS频率较高。 BC在群体中没有什么不同。 AI患者患MS与总脂肪和体脂指数(所有标准)的增加,以及MS与较小的BMI调整后瘦物质(AACE,P = 0.036)之间的显着差异。用BC或MS测试1mg地塞米松测试后的皮质醇无关。 AI和WC与MS.Conclusionsai独立相关,呈现高频MS,与MS独立相关。皮质醇分泌的可能有害效果似乎最初影响肌肉系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号